Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus - In Tertiary Care Center

Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus - In Tertiary Care Center

Introduction: T2DM is strongly associated with an increased prevalence of cardiovascular disease (CVD). It has been established that CVD is the main cause of mortality among patients with type 2 diabetes mellitus (T2DM) contributing to 80% of fatal outcomes. The consistent relationship between T2DM...

Full description

Saved in:

Bibliographic Details
Main Authors:	Akansha Singh, Ranjit S. Ambad, Roshan Kumar Jha
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-05-01
Series:	Journal of Pharmacy and Bioallied Sciences
Subjects:	coronary heart disease cardiovascular disease high-density lipoprotein low-density lipoprotein type 2 diabetes mellitus very low density lipoprotein
Online Access:	https://journals.lww.com/10.4103/jpbs.jpbs_1975_24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Discordance Between Very Low‐Density Lipoprotein Cholesterol and Low‐Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort
by: Kristina E. Seehusen, et al.
Published: (2024-04-01)

The effects of non-nutritive sweeteners on lipid profile in adults: a systematic review and meta-analysis of randomized controlled clinical trials
by: AmirHossein Najafi, et al.
Published: (2025-07-01)

Lipid Profile of the Patient with Acute Coronary Syndromes Undergoing Coronary Angiography (CAG) in Rural Costal Region of Maharashtra
by: Deshpande Janhavi JAYWANT, et al.
Published: (2021-12-01)

Addressing Dyslipidaemia in Advanced CKD: Insights from a Secondary Care Cohort
by: Tom Siby, et al.
Published: (2025-05-01)

Correlation of lipid profiles with coronary artery plaque levels in patients undergoing coronary angiography
by: Sedanur Uzunpolat Yayla, et al.
Published: (2024-04-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
by: Alberico L. Catapano, et al.
Published: (2017-06-01)

Atherogenic Index of Plasma in Acute Coronary Syndrome: An Observational Study in a Tertiary Care Hospital
by: Surya Kantha Bugge
Published: (2023-12-01)

Effects of a competitive season on the plasma lipid profile of soccer players
by: Santo Marsigliante, et al.
Published: (2025-05-01)

BLOOD LIPOPROTEINS AS A PLATFORM FOR TRANSPORT OF HYDROPHILIC AND HYDROPHOBIC COMPOUNDS
by: L. M. Polyakov, et al.
Published: (2019-09-01)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
by: Francois Mach, et al.
Published: (2020-06-01)

Effects of Inclisiran, Alirocumab, Evolocumab, and Evinacumab on Lipids: A Network Meta-Analysis
by: Lin Zhang, et al.
Published: (2025-02-01)

MODIFIED LOW-DENSITY LIPOPROT EINS IN DI ABETES MELLITUS TYPE 2
by: O. M. Drapkina, et al.
Published: (2018-07-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective
by: Yan Chen, et al.
Published: (2025-07-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Association of low-density lipoprotein/high-density lipoprotein ratio with cognition, Alzheimer’s disease biomarkers and brain structure
by: Zihao Zhang, et al.
Published: (2025-04-01)

ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk
by: A. N. Meshkov, et al.
Published: (2022-11-01)

The serum cholesterol level of choledocholithiasis patients was significantly lower than that of healthy people
by: Linzhen Li, et al.
Published: (2025-05-01)

An Efficacy of Seligi Leaf Flour Fermentation on Cholesterol Levels, Low Density Lipoprotein, and High Density Lipoprotein in Catfish
by: Reza Hardiansyah, et al.
Published: (2022-04-01)

Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
by: Li He, et al.
Published: (2025-07-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City
by: Maisha Maliha, et al.
Published: (2025-01-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
by: Alberto Zambon
Published: (2020-04-01)

Effect of aqueous extract of olive (Olea europaea) fruit on lipid profile in female rabbits
by: Baghdad Science Journal
Published: (2010-12-01)

Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study)
by: P. S. Sadovnikov, et al.
Published: (2024-10-01)

Efektifitas Probiotik Lactobacillus casei dan Lactobacillus rhamnosus Sebagai Pengganti Antibiotic Growth Promoter Terhadap Total Kolesterol, Low Density Lipoprotein dan High Density Lipoprotein Ayam Broiler
by: Anita Dwi Andriani, et al.
Published: (2020-03-01)

Beyond LDL-C: discordant small dense LDL cholesterol stratifies hypertension risk in a Chinese longitudinal cohort
by: Xiaofei Wu, et al.
Published: (2025-06-01)

Association of Lipid Profile with the Severity of Diabetic Retinopathy: A Cross-sectional Study
by: T Shakthiya, et al.
Published: (2025-02-01)

Age and gender characteristics of dyslipidemia prevalence among the Bishkek city residents
by: T. M. Murataliev, et al.
Published: (2019-04-01)

АSSOCIATION BETWEEN OXIDATIVE-ANTIOXIDANT MODIFICATIONS OF LOW-DENSITY LIPOPROTEINS AND CORONARY HEART DISEASE IN A MALE POPULATION OF NOVOSIBIRSK
by: Yu. I. Ragino, et al.
Published: (2013-12-01)

Lipid-lowering treatment in the improvement of outcomes in patients with atherosclerotic cardiovascular disease and diabetes mellitus: the role of PCSK9 inhibitors
by: G. R. Galstyan, et al.
Published: (2018-12-01)

Latest Indian Guidelines for Dyslipidemia Management: A Biochemist’s Perspective
by: Shalini Gupta
Published: (2024-12-01)

Machine learning-driven insights into lipid metabolism and inflammatory pathways in knee osteoarthritis
by: Tian-Ming Man, et al.
Published: (2025-02-01)

The individual empowerment program improves glycemic and lipid controls in admitted type 2 DM patients
by: Ampornpan Theeranut, et al.
Published: (2018-05-01)

Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"
by: G. P. Arutyunov, et al.
Published: (2022-09-01)

Association of LDL Cholesterol and hs-CRP with Subtypes of Heart Failure in Type 2 Diabetes Mellitus Patients: A Cross-sectional Study
by: Vineetha Naga Lakshmi Giduturi, et al.
Published: (2025-08-01)

Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low‐Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE‐IT Randomized Trial
by: Rahul Aggarwal, et al.
Published: (2025-03-01)

Study on the correlation between oxidized low- density lipoprotein and oxidized high- density lipoprotein with type 2 diabetes complicated by pulmonary tuberculosis
by: Jing Gui, et al.
Published: (2025-05-01)

Niacin and Stroke: The Role of Supplementation and Emerging Concepts in Clinical Practice, a Narrative Review
by: Alan D. Kaye, et al.
Published: (2025-05-01)

Assessing the impact of aggressive versus intermediate LDL-C goal achievement in Asian adults: a retrospective cohort study using national health insurance service-senior cohort
by: Yu-Cheol Lim, et al.
Published: (2025-08-01)